On Monday, the US Supreme Court issued a temporary order restoring access to the abortion pill mifepristone, blocking a federal appeals court ruling that imposed new restrictions. Justice Samuel Alito's order allows women to obtain the pill at pharmacies or by mail without needing an in-person consultation with a doctor. This ruling is significant as the majority of abortions in the US are conducted using medication, specifically mifepristone combined with misoprostol. The availability of these medications has mitigated the effects of abortion bans enacted by several Republican-led states following the Supreme Court's 2022 decision that overturned Roe v. Wade. Louisiana's lawsuit aimed to restrict access to mifepristone, claiming it undermined the state's abortion ban. Meanwhile, some Democratic-led states have enacted laws to protect telehealth prescriptions for these drugs. Alito's order will remain in effect for another week while the court considers the responses from both sides.